Document Type : Original Research

Authors

1 Reference Health Laboratory of Iran, Ministry of Health and Medical Education, Tehran, Iran

2 Shahid Rajaii Center for Educational Research and Clinical Cardiology, Tehran, Iran

10.30699/ijp.2024.2013702.3192

Abstract

Background & Objective: Providing equitable access to good quality, timely, and affordable laboratory testing has always been a top priority for the Ministry of Health and Medical Education (MoH-ME) and the Reference Health Laboratory (RHL). Considering the significant role of medical laboratories in disease surveillance, RHL developed a strategic plan to manage laboratory services during the COVID-19 pandemic based on the “Strategic Framework for strengthening health laboratory services, 2016-2020” proposed by the World Health Organization (WHO). This article describes the steps taken to establish the strategic framework in Iran.
Methods: Firstly, a National Laboratory Committee was formed in MoH-ME and a situation analysis was conducted to explore the strengths, weaknesses, opportunities, and threats in different components of our laboratory system. Gaps and resources needed to address those gaps were determined; then, RHL outlined operational processes and mechanisms for monitoring the activities.
Results: The WHO strategic roadmap and its six strategic goals concerning leadership, quality, human resources, safety and security, laboratory networking, and rational use of laboratory testing, helped us to promote national laboratory services in accordance with health system requirements in the COVID-19 pandemic.
Conclusion: The establishment of a national molecular laboratory network with more than 500 laboratories from different sectors may result in timely access to countrywide laboratory services and would be beneficial for future COVID-19 and/or other viral outbreaks. Continual evaluation of the COVID-19 laboratories' performance, production of PCR test kits by the local manufacturers, and development of a platform for virtual training would be other accomplishments that Iran achieved in coping with the recent pandemic.

Keywords

  1. Rafieepour A, Masoumi G, Dehghani A. Health responses during the COVID-19 pandemic: An international strategy and experience analysis. Health Emerg Dis Quar. 2021;6(3):147-60. [DOI:10.32598/hdq.6.3.310.1]
  2. Khankeh H, Farrokhi M, Roudini J, Pourvakhshoori N, Ahmadi S, Abbasabadi-Arab M, Bajerge NM, Farzinnia B, Kolivand P, Delshad V, Khanjani MS. Challenges to manage pandemic of coronavirus disease (COVID-19) in Iran with a special situation: a qualitative multi-method study. BMC Public Health. 2021;21:1-9. [DOI:10.1186/s12889-021-11973-5] [PMID]
  3. Safadel N, Samiee SM, Dahim P, Khodaverdian K, Roodaki MM, Anjarani S, Farsi S, Sabooni M, Atefi A. The Process of Establishing and Managing a Laboratory Diagnostic Network in the COVID-19 Pandemic in Iran. Dep Health. 2022;13(Suppl 1):11-21. [DOI:10.34172/doh.2022.12]
  4. World Health Organization. Strategic framework for strengthening health laboratory services 2016–2020. World Health Organization. Regional Office for the Eastern Mediterranean; 2017.
  5. World Health Organization. Laboratory testing strategy recommendations for COVID-19: interim guidance, 21 March 2020. World Health Organization; 2020.
  6. World Health Organization. Critical preparedness, readiness and response actions for COVID-19: interim guidance, 27 May 2021. World Health Organization; 2021.
  7. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. [DOI:10.1001/jama.2020.2648] [PMID]
  8. Cho H, Ippolito D, Yu YW. Contact tracing mobile apps for COVID-19: Privacy considerations and related trade-offs. arXiv preprint arXiv:2003.11511. 2020 Mar 25.
  9. on COVID NC. Daily situation report on Coronavirus disease (COVID-19) in Iran; March 13, 2020. Archives of Academic Emergency Medicine. 2020;8(1).
  10. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323(16):1545-6. [DOI:10.1001/jama.2020.4031] [PMID]
  11. World Health Organization. Turkey's response to COVID-19: first impressions. Ankara, Turkey. 11 July 2020. World Health Organization. Regional Office for Europe; 2020.
  12. Gupta N, Bhatnagar T, Rade K, Murhekar M, Gangakhedkar RR, Nagar A, ICMR COVID Team. Strategic planning to augment the testing capacity for COVID-19 in India. Indian J Med Res. 2020;151(2-3):210. [DOI:10.4103/ijmr.IJMR_1166_20] [PMID]
  13. Health Canada, issuing body. Priority strategies to optimize testing and screening for COVID-19 in Canada: Report. H164-312-2021-eng.pdf Ottawa, ON: Health Canada. 2021.
  14. PAHO/WHO Collaborating Centers. Videos: on the Proper use of PPE, Sample Collection, and Specimen Packaging. PAHO Digital Library (IRIS).
  15. World Health Organization. Laboratory biosafety guidance related to coronavirus disease (COVID-19): interim guidance, 28 January 2021. World Health Organization; 2021.
  16. World Health Organization. Laboratory biosafety guidance related to coronavirus disease (COVID-19): interim guidance, 28 January 2021. World Health Organization; 2021.
  17. World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020. World Health Organization; 2020.
  18. World Health Organization. Laboratory assessment tool for laboratories implementing SARS-CoV-2 testing: annex 2: laboratory assessment tool/facility questionnaire, 2 October 2020. World Health Organization; 2020.
  19. World Health Organization. Islamic Republic of Iran's US$ 50 Million Emergency Response Project (ICERP) for COVID-19 scales up nationwide response. World Health Organization. Regional Office for the Eastern Mediterranean; 2021.
  20. Khan SH, Zaidi SK, Gilani M. PCR to CRISPR: Role of Nucleic Acid Tests (NAT) in detection of COVID-19. JPMA. J Pak Med Assoc. 2022;72(6):1166-74. [DOI:10.47391/JPMA.2324] [PMID]
  21. World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays: interim guidance, 11 September 2020. World Health Organization; 2020.